Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ablation, ACR, adult, AiPC, Allen, alter, Alzheimer, ambulatory, angiotensin, appendix, ascending, ascertaining, auction, augment, automation, BACE, beleive, BMS, bruce, burakoff, Celgene, chemokine, CHMP, chosen, circumstance, CLD, closure, Cold, combinatorial, complement, CONBRIZA, COPD, Cranbury, cure, curtail, customary, CVR, DARA, decoded, deconvolution, DEF, degrade, depression, devote, diabetic, diastolic, digit, diligence, diminished, dispensing, distinguishing, Docetaxel, double, downturn, easily, Eastpark, economy, encoded, encoding, endothelin, energy, enjoining, enzyme, eventual, expend, experimental, feasibility, feature, fibrotic, FINRA, fluorescent, forecast, FSP, geopolitical, GLP, GPCR, Guarantor, heightened, Heilman, hierarchy, highest, hit, IIa, IIb, immunological, Importantly, incorrect, incurrence, indefinite, inflation, inhibit, inhibitor, innovation, insolvency, insolvent, irbesartan, Johnston, kinase, labor, Latour, layout, lending, Leslie, lowest, managerial, MAP, Margaux, married, membrane, Mercer, mg, momentum, MOU, nanovolume, nephropathy, ninety, nL, nonfinancial, nuclear, occupancy, ocular, oil, outlined, Oxford, Panel, paradigm, peacock, Phamacopeia, Pharmacopeia, physicochemical, plate, Plough, PoC, Polymeric, polystyrene, potent, precipitated, prejudice, preliminarily, prioritize, proof, prove, RA, rata, reagent, recession, refurbishment, Reg, regression, residential, respiratory, Revolade, sabba, Schering, seated, SmithKlineBeecham, splenectomy, Spring, stephen, steven, strain, stroke, sublicensee, systolic, tabular, tagging, Takeda, tangible, therefrom, Thornton, thousand, thrombotic, throughput, Trevena, turmoil, unanimously, uneconomical, unemployment, unidentified, unregistered, unwanted, valuable, wedded, world, wrongful, wrote
Removed:
absorption, acceleration, acne, added, adjust, affecting, affiliated, Aliprandi, allergic, alopecia, amend, androgenetic, APB, apparent, appointment, approximating, area, attractive, Baylor, BDO, benign, Bio, bioavailable, burdened, buyer, Cambrex, capitalized, Castle, CE, characterize, cholesterol, clarify, clinically, College, committed, consolidate, count, created, Crouch, define, demonstrated, density, destruction, determinable, distribute, eligible, enhanced, entry, Eric, estrogen, evolving, explore, facilitate, failed, Ferrer, fertility, finite, fluctuate, forfeiture, formed, formula, formulation, furnish, furnished, Greece, gynecological, headquarter, hereinafter, hirsutism, Hopkinton, hormonally, hormone, hospital, Howard, hyperplasia, immunogenic, improved, improvement, injectable, instrument, integrated, interact, invested, investigator, invoice, involvement, LGNDE, licensee, male, manipulate, menopause, mice, mimic, modulator, moved, natural, negotiate, neutralizing, objective, Oporia, pain, pattern, persuasive, Pettit, pioneering, platelet, Portugal, predicting, prevalence, prevalent, proceed, professor, profitability, progesterone, quantify, realizable, recourse, recovery, reflecting, reliably, relisted, rendered, reserved, resolve, responsive, Ronald, secondary, seller, Sergio, SERM, simplify, South, Spain, Stimulating, strive, supplemental, Taylor, thereon, tier, track, type, undergoing, universe, unprofitable, utilized, variance, vasomotor, vigorously, Warner, white, William
Filing tables
Filing exhibits
- 10-K Annual report
- 10.323 Pharmacopeia, Inc. 2000 Stock Option Plan
- 10.324 Collaboration and License Agreement
- 10.325 Collaboration and License Agreement
- 10.327 Lease Between Pharmacopeia, Inc. and Eastpark at 8A
- 10.329 Lease Between Pharmacopeia, Inc. and Eastpark at 8A
- 10.346 License Agreement
- 23.1 Consent of Independent Registered Public Accounting Firm - Grant Thornton LLP
- 23.2 Consent of Independent Registered Public Accounting Firm - Bdo Seidman, LLP
- 31.1 Section 302 Certification by Principal Executive Officer
- 31.2 Section 302 Certification by Principal Financial Officer
- 32.1 Section 906 Certification by Principal Executive Officer
- 32.2 Section 906 Certification by Principal Financial Officer
Related press release
LGND similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our reports dated March 13, 2009, with respect to the consolidated financial statements, schedule, and internal control over financial reporting included in the Annual Report of Ligand Pharmaceuticals Incorporated on Form 10-K for the year ended December 31, 2008. We hereby consent to the incorporation by reference of said report in the Registration Statements of Ligand Pharmaceuticals Incorporated on Form S-8 (File No. 333-131029, effective June 18, 2007).
/s/ Grant Thornton LLP
San Diego, California
March 13, 2009